ABSTRACT
A family history of breast cancer is one of the major criteria for inclusion into the tamoxifen experiment, the issues of which are discussed in. It appears that obesity confers not only an increased risk for breast cancer, but an increased risk for heart disease, hypertension, and degenerative arthritis. Clearly, the question of obesity and breast cancer involves more than good health practices. There is evidence that women and their close relatives who develop ovarian and endometrial cancer are at increased risk for breast cancer. The ultimate findings of incidence and distribution of breast cancer, connected to these products, will not be revealed until women who used them pass menopause. In the final analysis, if we consider that the traditional risk factors account for perhaps 30" of breast cancers. We are left with the fact that more than 70" of women who develop breast cancer have none of the traditional factors linked to breast cancer risk.
